Spectrum Pharma (SPPI) – Momentum Movers
-
Spectrum Pharma (SPPI) Gains 19% Following ASCO Abstract
-
Spectrum Pharma (SPPI) Sees Sharp Early Gains Following EGFR Exon 20 NSCLC Abstract; Analyst Says Data Was 'Very Encouraging'
-
-
-
-
-
-
Back to SPPI Stock Lookup